Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,156.73
-17.8800-1.52%
Pre-market: 1,175.0018.27+1.58%09:05 EDT
Volume:3.06M
Turnover:3.54B
Market Cap:1.09T
PE:38.83
High:1,171.45
Open:1,168.47
Low:1,147.00
Close:1,174.61
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:1.27
T/O Rate:0.33%
Dividend:6.46
Dividend Rate:0.56%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:32.28
PE(LYR):50.40

Loading ...

Novo Nordisk Wins EU Approval for Wegovy Weight-loss Pill

Reuters
·
Jul 16

Eli Lilly is Maintained at Buy by Citigroup

Dow Jones
·
Jul 15

This Wall Street 'theme-o-meter' Has a Clear Message: the Artificial-intelligence Bull Market is Back

Dow Jones
·
Jul 15

VivoSim Receives $5 Million Eli Lilly Milestone Payment, Issues Fiscal 2027 Revenue Growth Outlook

MT Newswires Live
·
Jul 15

VivoSim receives $5M milestone payment from Eli Lilly

TIPRANKS
·
Jul 15

Vivosim Labs - Eligible for up to $45 Mln in Additional Milestone Payments from Eli Lilly

THOMSON REUTERS
·
Jul 15

Market Chatter: Eli Lilly-Backed AdvanCell Raises $315 Million From New Funding Round

MT Newswires Live
·
Jul 15

Citigroup Adjusts Price Target on Eli Lilly to $1,600 From $1,500, Maintains Buy Rating

MT Newswires Live
·
Jul 15

Novo Nordisk Takes Early Lead in Oral Weight-Loss Drug Market, Eli Lilly Aims to Catch Up

Deep News
·
Jul 15

In the Weight-loss Wars, Novo's Obesity Pill is Pulling Way Ahead of Lilly's

Dow Jones
·
Jul 15

Eli Lilly Wins Full FDA Approval for Selpercatinib in Solid Tumors

MT Newswires Live
·
Jul 15

Retevmo granted FDA traditional approval for RET fusion-positive solid tumors

TIPRANKS
·
Jul 15

FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic Ret Fusion-positive Solid Tumors

THOMSON REUTERS
·
Jul 15

Eli Lilly is Maintained at Outperform by Bernstein

Dow Jones
·
Jul 14

Eli Lilly : Bernstein Raises Target Price to $1385 from $1300

THOMSON REUTERS
·
Jul 14

Movement Alert|Eli Lilly Falls 3.11% in Regular Trading, Patent Lawsuit Restart Compounds Sector-Wide Profit-Taking

Market Focus
·
Jul 14

Eli Lilly and Co Stock (LLY) Moved Down by 3.10% on Jul 14: Facts Behind the Movement

TradingKey
·
Jul 14

Eli Lilly price target raised to $1,385 from $1,300 at Bernstein

TIPRANKS
·
Jul 14

US Appeals Court Revives Teva Lawsuit over Lilly Osteoporosis Drug

Reuters
·
Jul 14

Eli Lilly Stock (LLY) Gets a Price Target Boost Heading into Earnings

TIPRANKS
·
Jul 14